Association Between the Duration of Hearing Loss and Hearing Outcomes in Surgery for Otosclerosis.


Journal

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
ISSN: 1097-6817
Titre abrégé: Otolaryngol Head Neck Surg
Pays: England
ID NLM: 8508176

Informations de publication

Date de publication:
05 2021
Historique:
pubmed: 14 10 2020
medline: 9 7 2021
entrez: 13 10 2020
Statut: ppublish

Résumé

Hearing loss due to otosclerosis is effectively treated with surgery. The association between duration of hearing loss and surgical outcomes is unknown. Retrospective review. Large otology referral center. Patients undergoing primary stapes surgery for otosclerosis from 2005 to 2017 were evaluated according to their self-reported duration of hearing loss. Closure of the air-bone gap (ABG) was the primary outcome measure. A total of 580 stapes operations were included. Sixteen percent of patients reported hearing loss for ≤1 year; 25%, >1 to ≤5 years; 24%, >5 to ≤10 years; 24%, >10 to ≤20 years; and 12%, >20 years, respectively. Average pre- and postoperative ABGs were 26.1 and 9.6 dB ( Otosclerosis is effectively treated with surgery even after a long duration of hearing loss, provided that sensorineural hearing and word recognition are favorable. Although far-advanced otosclerosis has known poorer hearing outcomes after stapes surgery, a long duration of hearing loss is an unreliable surrogate for this.

Identifiants

pubmed: 33048616
doi: 10.1177/0194599820964726
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1094-1099

Auteurs

Alexander L Luryi (AL)

Department of Neurotology, Michigan Ear Institute, Farmington Hills, Michigan, USA.

Amy Schettino (A)

Department of Otolaryngology-Head and Neck Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Seilesh C Babu (SC)

Department of Neurotology, Michigan Ear Institute, Farmington Hills, Michigan, USA.

Dennis I Bojrab (DI)

Department of Neurotology, Michigan Ear Institute, Farmington Hills, Michigan, USA.

Elias M Michaelides (EM)

Department of Otorhinolaryngology-Head and Neck Surgery, Rush University, Chicago, Illinois, USA.

Dennis I Bojrab (DI)

Department of Neurotology, Michigan Ear Institute, Farmington Hills, Michigan, USA.

Christopher A Schutt (CA)

Department of Neurotology, Michigan Ear Institute, Farmington Hills, Michigan, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH